Differences
This shows you the differences between two versions of the page.
Next revision | Previous revision | ||
potassium [2025/01/28 06:36] – created admin | potassium [2025/01/28 06:39] (current) – admin | ||
---|---|---|---|
Line 3: | Line 3: | ||
Potassium Examination Procedure | Potassium Examination Procedure | ||
- | 1.Purpose of Examination: | + | **1.Purpose of Examination: |
To lay down standard operating procedure for serum Potassium by ISE Method in Biochemistry section of LSSTH, Bhavnagar. | To lay down standard operating procedure for serum Potassium by ISE Method in Biochemistry section of LSSTH, Bhavnagar. | ||
Line 14: | Line 14: | ||
**4.Primary Sample:** | **4.Primary Sample:** | ||
- | Plasma or serum | + | Plasma or serum [[sample_collection_manual|]] |
**5.Patient Preparation: | **5.Patient Preparation: | ||
Line 68: | Line 68: | ||
**20.Turn around time (TAT)** | **20.Turn around time (TAT)** | ||
- | | + | 6.0 hours after collection, in case of emergency 2.0 hours. |
**21.Critical Value:** | **21.Critical Value:** | ||
Line 99: | Line 99: | ||
- Young D.S., Effects of Drugs on Clinical Laboratory Tests, AACc Press Washington, D.C., 1990. | - Young D.S., Effects of Drugs on Clinical Laboratory Tests, AACc Press Washington, D.C., 1990. | ||
- Document EP3-T: | - Document EP3-T: | ||
- | - | + | - Roche Ise Indirect Na K Cl05883962001c501V13.0 |
- | - | + | - NABL 112 effective from 01/06/2019 |
|**Printed copy of this document is considered uncontrolled.** It should be compared with controlled electronic copy before use| | |**Printed copy of this document is considered uncontrolled.** It should be compared with controlled electronic copy before use| |